Wei Zhang

机构：Nanjing University of Chinese Medicine, Central South University, Guilin Medical University, Capital Medical University, Nantong University, Nanjing General Hospital of Nanjing Military Command, Soochow University, Affiliated Hospital of Nantong University, Beijing Tian Tan Hospital, Tianjin Centers for Disease Control and Prevention, Tianjin Infectious Diseases Hospital, First Affiliated Hospital of Soochow University, Third Xiangya Hospital, Xijing Hospital, Liaocheng People's Hospital, Second Affiliated Hospital of Nantong University, Lanzhou University, Nanjing University, Air Force Medical University · ORCID：0000-0001-8679-6713

发表论文 114 篇 · 总被引 5569 次 · h-index 30

代表论文

• Vitamin D receptor attenuate ischemia-reperfusion kidney injury via inhibiting ATF4 (2023 · Cell Death Discovery · 被引 25)
• Multi-phoretic nanomotor with consistent motion direction for enhanced cancer therapy (2024 · Acta Biomaterialia · 被引 22)
• Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives (2023 · Pharmaceutics · 被引 21)
• Cinnamaldehyde Alleviates Bone Loss by Targeting Oxidative Stress and Mitochondrial Damage via the Nrf2/HO-1 Pathway in BMSCs and Ovariectomized Mice (2023 · Journal of Agricultural and Food Chemistry · 被引 19)
• The latest applications of exosome-mediated drug delivery in anticancer therapies (2025 · Colloids and Surfaces B Biointerfaces · 被引 13)
• The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy (2024 · Frontiers in Pharmacology · 被引 12)